Journal article
Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry.
-
D'Atri V
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland. Electronic address: valentina.datri@unige.ch.
-
Fekete S
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland.
-
Stoll D
Department of Chemistry, Gustavus Adolphus College, Saint Peter, Minnesota 56082, United States.
-
Lauber M
Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757-3696, United States.
-
Beck A
Center of Immunology Pierre Fabre, 5 Avenue Napoléon III, BP 60497, Saint-Julien-en-Genevois, France.
-
Guillarme D
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, CMU - Rue Michel Servet 1, 1211 Geneva 4, Switzerland.
Show more…
Published in:
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. - 2018
English
Brentuximab vedotin (Adcetris) is a cysteine-linked antibody-drug conjugate (ADC) used in the treatment of Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). In this study, the drug payload and glycan modifications of this ADC were simultaneously characterized using a unique LC-MS middle-up analysis, involving hydrophilic interaction chromatography (HILIC). This work demonstrates that HILIC is an effective and complementary analytical technique to reversed phase liquid chromatography (RPLC) for subunit-level characterization of immuno-conjugates.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/170299
Statistics
Document views: 27
File downloads: